{"id":"https://openalex.org/W2164367180","doi":null,"title":"Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.","display_name":"Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.","publication_year":2012,"publication_date":"2012-03-01","ids":{"openalex":"https://openalex.org/W2164367180","mag":"2164367180","pmid":"https://pubmed.ncbi.nlm.nih.gov/22399496","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5536098"},"language":"en","primary_location":{"id":"pmid:22399496","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22399496","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer genomics & proteomics","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5536098","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040654673","display_name":"Jagannath Pal","orcid":"https://orcid.org/0000-0002-7110-4048","observed_orcids":["https://orcid.org/0000-0002-7110-4048"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jagannath Pal","raw_affiliation_strings":["Department of Adult Oncology, Harvard (Dana Farber) Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Adult Oncology, Harvard (Dana Farber) Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017577287","display_name":"Puru Nanjappa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Puru Nanjappa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036264384","display_name":"Leutz Buon","orcid":"https://orcid.org/0009-0000-5990-1936","observed_orcids":["https://orcid.org/0009-0000-5990-1936"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leutz Buon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019802024","display_name":"Yu\u2010Tzu Tai","orcid":"https://orcid.org/0000-0001-6199-3569","observed_orcids":["https://orcid.org/0000-0001-6199-3569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-Tzu Tai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077467836","display_name":"Pierfrancesco Tassone","orcid":"https://orcid.org/0000-0002-8298-6787","observed_orcids":["https://orcid.org/0000-0002-8298-6787"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierfrancesco Tassone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikhil C Munshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masood A Shammas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5137,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.63500049,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"9","issue":"2","first_page":"55","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.7670999765396118,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.7670999765396118,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.1923000067472458,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/barrett-s-adenocarcinoma","display_name":"Barrett's adenocarcinoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.9120000004768372},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.8980000019073486},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.9879999756813049},{"id":"https://openalex.org/keywords/wortmannin","display_name":"wortmannin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dna-damage-checkpoint","display_name":"DNA damage checkpoint","score":0.7649999856948853},{"id":"https://openalex.org/keywords/atr-chk1-pathway","display_name":"ATR-Chk1 pathway","score":0.8360000252723694},{"id":"https://openalex.org/keywords/chk2","display_name":"Chk2","score":0.8659999966621399},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.7900000214576721},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.7390000224113464},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.3709999918937683},{"id":"https://openalex.org/keywords/esophageal-adenocarcinoma","display_name":"esophageal adenocarcinoma","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2778308172","wikidata":"https://www.wikidata.org/wiki/Q423565","display_name":"Wortmannin","level":4,"score":0.9344037175178528},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.7208858728408813},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6877436637878418},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6447303295135498},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.6174718737602234},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.49968576431274414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47990497946739197},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.45605939626693726},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4427371919155121},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4034750461578369},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.32093167304992676},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.10848194360733032},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08284008502960205}],"mesh":[{"descriptor_ui":"D000077191","descriptor_name":"Wortmannin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016000","descriptor_name":"Cluster Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051135","descriptor_name":"Rad51 Recombinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051135","descriptor_name":"Rad51 Recombinase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051135","descriptor_name":"Rad51 Recombinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058539","descriptor_name":"Phosphatidylinositol 3-Kinase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058539","descriptor_name":"Phosphatidylinositol 3-Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:22399496","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22399496","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer genomics & proteomics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5536098","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5536098","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Genomics Proteomics","raw_type":"Text"},{"id":"mag:2164367180","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/22399496","pdf_url":null,"source":{"id":"https://openalex.org/S4210194588","display_name":"Cancer Genomics & Proteomics","issn_l":"1109-6535","issn":["1109-6535","1790-6245"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Genomics & Proteomics","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5536098","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5536098","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Genomics Proteomics","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2377207763","display_name":"Telomerase And Homologous Recombination As Targets In Barrett's Adenocarcinoma","funder_award_id":"R01CA125711","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W28048863","https://openalex.org/W145627486","https://openalex.org/W406844001","https://openalex.org/W1965001189","https://openalex.org/W1976229190","https://openalex.org/W1976543436","https://openalex.org/W1979618604","https://openalex.org/W1982327595","https://openalex.org/W1984584382","https://openalex.org/W1984919526","https://openalex.org/W1990675767","https://openalex.org/W1992292526","https://openalex.org/W2002270566","https://openalex.org/W2010444615","https://openalex.org/W2014423532","https://openalex.org/W2015061258","https://openalex.org/W2016949934","https://openalex.org/W2021888737","https://openalex.org/W2027630134","https://openalex.org/W2029304297","https://openalex.org/W2030797511","https://openalex.org/W2032261226","https://openalex.org/W2035649344","https://openalex.org/W2038437697","https://openalex.org/W2048888997","https://openalex.org/W2050089545","https://openalex.org/W2055128617","https://openalex.org/W2086377914","https://openalex.org/W2087012714","https://openalex.org/W2088118561","https://openalex.org/W2093789049","https://openalex.org/W2094124228","https://openalex.org/W2100093188","https://openalex.org/W2101173900","https://openalex.org/W2105613345","https://openalex.org/W2105924300","https://openalex.org/W2107932846","https://openalex.org/W2111736935","https://openalex.org/W2119590886","https://openalex.org/W2119645999","https://openalex.org/W2136706606","https://openalex.org/W2136887968","https://openalex.org/W2145882598","https://openalex.org/W2154539063","https://openalex.org/W2160621707","https://openalex.org/W2160948246","https://openalex.org/W2164139183","https://openalex.org/W2168537389","https://openalex.org/W2183423932","https://openalex.org/W2315803728","https://openalex.org/W2412674696","https://openalex.org/W2415249655"],"related_works":["https://openalex.org/W4233403192","https://openalex.org/W2044246794","https://openalex.org/W7097530643","https://openalex.org/W2109252212","https://openalex.org/W2131660936","https://openalex.org/W925623606","https://openalex.org/W2161242392","https://openalex.org/W2059620499","https://openalex.org/W2139807762","https://openalex.org/W2045836176"],"abstract_inverted_index":{"Phosphatidylinositol":[0],"3-kinase":[1],"(PI3K)/v-akt":[2],"murine":[3],"thymoma":[4],"viral":[5],"oncogene":[6],"homolog":[7],"1":[8,123],"(AKT)":[9],"signaling":[10,203],"in":[11,15,34,40,43,54,82,147,154,160,180,190,194,197,209,249],"cancer":[12],"is":[13,231],"implicated":[14],"various":[16],"survival":[17,217,240],"pathways":[18],"including":[19],"regulation":[20],"of":[21,57,68,95,158,166,178,188,228,244],"recombinase":[22],"(RAD51).":[23],"In":[24,111,222],"this":[25],"study,":[26],"we":[27],"evaluated":[28],"PI3K":[29,58,202,234,245],"and":[30,42,50,61,66,72,80,88,108,118,126,133,149,168,170,196,204,213,236,246],"RAD51":[31,73,132,142,159,179,230],"as":[32],"targets":[33],"Barrett's":[35],"adenocarcinoma":[36],"(BAC)":[37],"cells":[38,162,223,250],"both":[39,193],"vitro":[41,195],"vivo.":[44,198],"BAC":[45,84,220],"cell":[46,85],"lines":[47,86],"(OE19,":[48],"OE33,":[49],"FLO-1)":[51],"were":[52,103,135],"cultured":[53],"the":[55,62,164,172,176,185],"presence":[56],"inhibitor":[59],"(wortmannin)":[60],"impact":[63],"on":[64],"growth":[65,78],"expression":[67,94,165,227],"AKT,":[69,229],"phosphorylated-AKT":[70],"(P-AKT),":[71],"was":[74,143],"determined.":[75],"Wortmannin":[76],"induced":[77],"arrest":[79],"apoptosis":[81],"two":[83],"(OE33":[87],"OE19),":[89],"which":[90],"had":[91],"relatively":[92],"higher":[93],"AKT.":[96],"FLO-1":[97,112,155,161,181],"cells,":[98,113,151,182,192],"with":[99,224,251],"lower":[100,252],"AKT":[101,253],"expression,":[102,254],"less":[104],"sensitive":[105],"to":[106,219],"treatment":[107],"investigated":[109],"further.":[110],"wortmannin":[114,146,189],"suppressed":[115,144],"ataxia":[116],"telangiectasia":[117],"Rad3-related":[119],"protein":[120],"(ATR)-checkpoint":[121],"kinase":[122],"(CHK1)-mediated":[124],"checkpoint":[125],"multiple":[127],"DNA":[128,210],"repair":[129,214],"genes,":[130],"whereas":[131],"CHK2":[134,167],"not":[136,153],"affected.":[137],"Western":[138],"blotting":[139],"confirmed":[140],"that":[141,201],"by":[145,233],"OE33":[148],"OE19":[150],"but":[152],"cells.":[156,221],"Suppression":[157],"down-regulated":[163],"CHK1,":[169],"reduced":[171],"proliferative":[173,259],"potential.":[174,260],"Finally,":[175],"suppression":[177,235,243],"significantly":[183,256],"increased":[184],"anticancer":[186],"activity":[187],"these":[191],"We":[199],"show":[200],"hsRAD51,":[205],"through":[206],"distinct":[207],"roles":[208],"damage":[211],"response":[212],"pathways,":[215],"provide":[216],"advantage":[218],"inherent":[225],"low":[226],"unaffected":[232],"provides":[237],"an":[238],"additional":[239],"pathway.":[241],"Simultaneous":[242],"RAD51,":[247],"especially":[248],"can":[255],"reduce":[257],"their":[258]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}